Accuray (ARAY) Free Cash Flow Growth (3y) (2013 - 2026)
Accuray (ARAY) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 41.96% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 25.48% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 35.42% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 250.09% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 12.01% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 35.65% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 20.87% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 9.23% |
| 10 | Accuray | 36.52 Mn | -3.18 Mn | 25.29 Mn | -70.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.04% |
| Dec 31, 2025 | -6.07% |
| Sep 30, 2025 | 125.57% |
| Mar 31, 2025 | 121.92% |
| Dec 31, 2024 | -61.89% |
| Sep 30, 2024 | 8.38% |
| Mar 31, 2024 | -39.43% |
| Dec 31, 2023 | -30.56% |
| Sep 30, 2023 | -41.21% |
| Mar 31, 2023 | 36.27% |
| Dec 31, 2022 | -46.17% |
| Sep 30, 2022 | 63.82% |
| Mar 31, 2022 | 49.06% |
| Dec 31, 2021 | 61.47% |
| Sep 30, 2021 | 19.71% |
| Mar 31, 2021 | 170.31% |
| Dec 31, 2020 | 132.76% |
| Sep 30, 2020 | 37.31% |
| Jun 30, 2020 | -12.11% |
| Mar 31, 2020 | 1.64% |